The EU announced Friday that it had struck a deal with French pharmaceutical giant Sanofi for 300 million doses of a potential coronavirus vaccine.
PARIS: Pharma giants Sanofi and GSK will receive up to US$2.1 billion from the US government for the development of a COVID-19 vaccine, the companies said on Friday , as the world scrambles for an answer to the pandemic.
The firms aim to combine a Sanofi-developed antigen, which stimulates the production of germ-killing antibodies, with GSK's adjuvant technology, a substance that bolsters the immune response triggered by a vaccine. Europe meanwhile has recorded nearly 210,000 deaths from 3.2 million cases, and with infections rising again in several countries there are fears a"second wave" of the pandemic could be on the way.
The latest investment holds the"potential to bring hundreds of millions of safe and effective doses to the American people," Azar said in the statement.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
US to pay US$2.1 billion to Sanofi, GSK, in COVID-19 vaccine dealThe U.S. government will pay US$2.1 billion to Sanofi SA and GlaxoSmithKline Plc for COVID-19 vaccines to cover 50 million people and to ...
Read more »
Sanofi, GSK reach virus vaccine deals with US, EUThe EU announced Friday that it had struck a deal with French pharmaceutical giant Sanofi for 300 million doses of a potential coronavirus vaccine.
Read more »
US to pay $2.9 billion to Sanofi, GlaxoSmithKline in Covid-19 vaccine dealWASHINGTON (REUTERS) - The US government will pay US$2.1 billion (S$2.89 billion) to Sanofi and GlaxoSmithKline for Covid-19 vaccines to cover 50 million people and to underwrite the drug makers' testing and manufacturing, the companies said on Friday (July 31).. Read more at straitstimes.com.
Read more »
Britain secures 60 million doses of Sanofi/GSK coronavirus vaccineBritain has signed a deal for up to 60 million doses of a potential coronavirus vaccine being developed by Sanofi and GlaxoSmithKline (GSK), it said on Wednesday, its latest such arrangement as the race to tame the pandemic heats up. With its four deals so far, Britain has struck more coronavirus vaccine
Read more »
EU warns of risk of syringe shortages for possible COVID-19 vaccineThe European Union has warned member states of the risk of shortages of syringes, wipes and protective gear needed for potential mass vaccinations ...
Read more »
EU okays with conditions Alstom's buy of Bombardier's rail businessEU antitrust regulators approved on Friday Alstom's bid for Bombardier Inc's rail business after the French TGV high-speed train maker agreed to ...
Read more »